DZ1335A1 - Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus. - Google Patents

Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus.

Info

Publication number
DZ1335A1
DZ1335A1 DZ890060A DZ890060A DZ1335A1 DZ 1335 A1 DZ1335 A1 DZ 1335A1 DZ 890060 A DZ890060 A DZ 890060A DZ 890060 A DZ890060 A DZ 890060A DZ 1335 A1 DZ1335 A1 DZ 1335A1
Authority
DZ
Algeria
Prior art keywords
furo
enantiomers
pyridine
compound
preparation
Prior art date
Application number
DZ890060A
Other languages
English (en)
French (fr)
Inventor
Marc Bonato
Charles R Eck
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DZ1335A1 publication Critical patent/DZ1335A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DZ890060A 1988-04-06 1989-04-01 Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus. DZ1335A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives

Publications (1)

Publication Number Publication Date
DZ1335A1 true DZ1335A1 (fr) 2004-09-13

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ890060A DZ1335A1 (fr) 1988-04-06 1989-04-01 Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus.

Country Status (28)

Country Link
US (1) US5026855A (en:Method)
EP (1) EP0337858B1 (en:Method)
JP (1) JP2680456B2 (en:Method)
KR (1) KR970005308B1 (en:Method)
AT (1) AT397093B (en:Method)
AU (1) AU616753B2 (en:Method)
BE (1) BE1003843A4 (en:Method)
CA (1) CA1338475C (en:Method)
CH (1) CH680000A5 (en:Method)
DK (1) DK167020B1 (en:Method)
DZ (1) DZ1335A1 (en:Method)
ES (1) ES2057159T3 (en:Method)
FI (1) FI93116C (en:Method)
FR (2) FR2629821B1 (en:Method)
GB (2) GB8808001D0 (en:Method)
IE (1) IE61915B1 (en:Method)
IN (1) IN172987B (en:Method)
MA (1) MA21529A1 (en:Method)
MY (1) MY104424A (en:Method)
NL (1) NL8920307A (en:Method)
NZ (1) NZ228614A (en:Method)
OA (1) OA09247A (en:Method)
PT (1) PT90210B (en:Method)
SE (1) SE509130C2 (en:Method)
SG (1) SG40492G (en:Method)
TN (1) TNSN89043A1 (en:Method)
WO (1) WO1989009772A1 (en:Method)
ZA (1) ZA892477B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
EP2485734B1 (en) * 2009-10-09 2014-07-02 Merck Sharp & Dohme Corp. Diuretics
US9522138B2 (en) * 2013-12-31 2016-12-20 Don C. Rockey Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (en:Method) * 1981-02-10 1985-11-09 Scras
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (en:Method) * 1983-04-05 1987-06-27 Scras
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
GB2235194A (en) 1991-02-27
FR2629820B1 (fr) 1993-12-03
EP0337858B1 (fr) 1994-06-08
FI93116B (fi) 1994-11-15
AT397093B (de) 1994-01-25
CH680000A5 (en:Method) 1992-05-29
JPH02504394A (ja) 1990-12-13
US5026855A (en) 1991-06-25
KR900700483A (ko) 1990-08-13
DK611689D0 (da) 1989-12-05
SE8904104D0 (sv) 1989-12-05
SE8904104L (sv) 1989-12-05
IE61915B1 (en) 1994-11-30
IN172987B (en:Method) 1994-01-15
NL8920307A (nl) 1990-03-01
ZA892477B (en) 1989-12-27
MY104424A (en) 1994-03-31
GB8808001D0 (en) 1988-05-05
FI895826A0 (fi) 1989-12-05
AU616753B2 (en) 1991-11-07
CA1338475C (en) 1996-07-23
KR970005308B1 (ko) 1997-04-15
AU3419089A (en) 1989-11-03
GB8927509D0 (en) 1990-06-13
ES2057159T3 (es) 1994-10-16
GB2235194B (en) 1992-01-29
EP0337858A1 (fr) 1989-10-18
NZ228614A (en) 1990-11-27
DK167020B1 (da) 1993-08-16
JP2680456B2 (ja) 1997-11-19
FR2629820A1 (fr) 1989-10-13
PT90210A (pt) 1989-11-10
IE891076L (en) 1989-10-06
SG40492G (en) 1992-06-12
PT90210B (pt) 1994-06-30
ATA900589A (de) 1993-06-15
SE509130C2 (sv) 1998-12-07
FI93116C (fi) 1995-02-27
BE1003843A4 (fr) 1992-06-30
FR2629821A1 (fr) 1989-10-13
OA09247A (fr) 1992-06-30
MA21529A1 (fr) 1989-12-31
DK611689A (da) 1989-12-05
FR2629821B1 (fr) 1993-12-03
WO1989009772A1 (fr) 1989-10-19
TNSN89043A1 (fr) 1991-02-04

Similar Documents

Publication Publication Date Title
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
CS8701093A2 (en) Method of new cycloalkano/1,2-b/-indolesulphoamides production
DZ1335A1 (fr) Procédé stéréospecifique pour la préparation des énantiomères de la furo (3,4-c) pyridine et composéainsi obtenus.
OA07766A (fr) Procédé de préparation de dérivés de cephème.
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
DZ701A1 (fr) Nouveaux dérivés de la vinyl-6, furo-(3,4-c)-pyridine ainsi que leur procédé de préparation.
HUT45727A (en) Process for production of vinilchlorid by thermic splitting of 1,2-dichlor-ethan
OA08383A (fr) Procédé de préparation d'urée.
OA08384A (fr) Procédé de préparation de l'urée.
AU6709086A (en) Process for producing molten iron
PT83913B (en) Process for the production of block copolymer of propylene
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
OA07674A (fr) Procédé de préparation de dérivés de carbapénem, nouveaux intermédiaires de synthèse et préparation de ces intermédiaires.
OA07202A (fr) Procédé pour la préparation de l'urée
HUT48571A (en) Process for production of substituated 3,5-dichlor-2,4-difluor-benzol
FR2709490B3 (fr) Procédé perfectionné pour la préparation de l'astaxanthine.
OA07833A (fr) Procédé de préparation de nouveaux dérivés de 1-(acétylamino)-2-amino-propanone.
DZ687A1 (fr) Dérivés de la chlori-4-furo-(3,4-c)-pyridine et leur procédé de préparation.
PT84209A (en) Process for the production of block copolymer of propylene
OA06952A (fr) Procédé nouveau de préparation des tétrahydro-5,6,7,7a 4H-thiéno (3,2-c) pyridinones-2.
OA06879A (fr) Procédé de préparation de dérivés d'hétéroprostaglandines.
MA20491A1 (fr) Procede de preparation d'aminomethylene-2 indanedione-1,3 substituees sur l'azote
FR2605318B1 (fr) Procede de preparation d'azetidinones.
OA07201A (fr) Procédé pour la préparation de l'urée .
OA08088A (fr) Nouveau procédé de préparation des dérivés de la furo-(3,4-C)-pyridine substitués en position 6.